Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children	Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Urogenital Diseases, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, nephritis, urinary system disorder	Recruiting	Not applicable	2026-08-28		NCT02235857

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Kaneka Medical America LLC	5

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Akron Children's Hospital	Akron	United States	38
Cedars Sinai Medical Center	Los Angeles	United States	135
Children's Hospital of Richmond at VCU	Richmond	United States	5
Helen DeVos Children's Hospital	Grand Rapids	United States	23
Loma Linda University Children's Hospital	Loma Linda	United States	7
Medical University of South Carolina Children's Hospital	Charleston	United States	4
Nemours Children's Health	Orlando	United States	8
Nemours/A.I. duPont Hospital for Children	Wilmington	United States	1
St. Christopher's Hospital for Children	Philadelphia	United States	3
University of Minnesota	Minneapolis	United States	30
University of North Carolina	Chapel Hill	United States	101
Weill Cornell Medical Center / NewYork-Presbyterian	New York	United States	1